Aquestive Therapeutics
AQST
AQST
56 hedge funds and large institutions have $101M invested in Aquestive Therapeutics in 2019 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.23% more ownership
Funds ownership: 54.25% → 54.47% (+0.23%)
0% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 12
Holders
56
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.3M | |
| 2 | +$2.65M | |
| 3 | +$2.04M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.82M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.53M |
Top Sellers
| 1 | -$969K | |
| 2 | -$934K | |
| 3 | -$519K | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$317K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$210K |